Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia

All-trans retinoic acid (ATRA)/arsenic trioxide (ATO) combination-based therapy has benefitted newly diagnosed acute promyelocytic leukemia (APL) in short-term studies, but the long-term efficacy and safety remained unclear. From April 2001, we have followed 85 patients administrated ATRA/ATO with a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hu, Jiong, Liu, Yuan-Fang, Wu, Chuan-Feng, Xu, Fang, Shen, Zhi-Xiang, Zhu, Yong-Mei, Li, Jun-Min, Tang, Wei, Zhao, Wei-Li, Wu, Wen, Sun, Hui-Ping, Chen, Qiu-Sheng, Chen, Bing, Zhou, Guang-Biao, Zelent, Arthur, Waxman, Samuel, Wang, Zhen-Yi, Chen, Sai-Juan, Chen, Zhu
Formato: Artigo
Lenguaje:Inglês
Publicado: National Academy of Sciences 2009
Materias:
Biological Sciences
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2651325/
https://ncbi.nlm.nih.gov/pubmed/19225113
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0813280106
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares